<abstract xmlns="http://www.w3.org/1999/xhtml"><p> We present a case of severe thromboembolic pulmonary hypertension in a patient with history of recurrent deep vein thrombosis and pulmonary restrictive disease due to pulmonary and vertebral tuberculosis in young adulthood. He was considered not eligible in the National Program for Primary Pulmonary Hypertension, being referred for thoracic surgery, but he was considered unfit for thrombendarterectomy. Despite guidelines, we administered him specific medical therapy (phosphodiesterase-5 inhibitors and endothelin receptor antagonists). His clinical evolution was satisfactory, with increasing effort tolerance and decreasing need for ambulatory oxigenotherapy.</p></abstract>

We present a case of severe thromboembolic pulmonary hypertension in a patient with history of recurrent deep vein thrombosis and pulmonary restrictive disease due to pulmonary and vertebral tuberculosis in young adulthood. He was considered not eligible in the National Program for Primary Pulmonary Hypertension, being referred for thoracic surgery, but he was considered unfit for thrombendarterectomy. Despite guidelines, we administered him specific medical therapy (phosphodiesterase-5 inhibitors and endothelin receptor antagonists). His clinical evolution was satisfactory, with increasing effort tolerance and decreasing need for ambulatory oxigenotherapy.

Favorable Evolution of a Patient with Thromboembolic Pulmonary Hypertension

ARS Medica Tomitana

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

{"article-title":"Favorable Evolution of a Patient with Thromboembolic Pulmonary Hypertension"}

We present a case of severe thromboembolic pulmonary hypertension in a patient with history of recurrent deep vein thrombosis and pulmonary restrictive disease...

Favorable Evolution of a Patient with Thromboembolic Pulmonary Hypertension

Pubblicato online: 17 mag 2017

Pagine: 94 - 98

DOI: https://doi.org/10.1515/arsm-2017-0017

Parole chiave
Pulmonary thromboembolic hypertension, thrombendarterectomy, phosphodiesterase-5 inhibitors, endothelin receptor antagonists

© by Irinel Raluca Parepa

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Favorable Evolution of a Patient with Thromboembolic Pulmonary Hypertension

Pubblicato online: 17 mag 2017

Pagine: 94 - 98

DOI: https://doi.org/10.1515/arsm-2017-0017

Parole chiavePulmonary thromboembolic hypertension, thrombendarterectomy, phosphodiesterase-5 inhibitors, endothelin receptor antagonists

© by Irinel Raluca Parepa

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Parole chiave
Pulmonary thromboembolic hypertension, thrombendarterectomy, phosphodiesterase-5 inhibitors, endothelin receptor antagonists